XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.
- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.
The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
Crypto Market Cap Rose 39% in Q3, Ending Losing Streak: Report
The global crypto market capitalization posted a 39% gain in Q3, snapping a three-consecutive-quarter losing streak, according to a CoinGecko industry report. T...
Ledger Implant Thieves Steal $4.8M Bitcoin From Task Scam Operator
Blockchain analytics firm Chainalysis has identified one of the largest victims of the Ledger hardware-wallet implant theft as a task scam operator, who lost mo...
Zcash NU7 Rules Would Block Sprout Pool Spending
Zcash’s proposed NU7 network upgrade would permanently block spending from the Sprout pool by invalidating version 4 transactions, the only transaction format t...
Aave Ethereum V3 Umbrella Stakes Fall 9.67% to $116.09M
Aave Umbrella is the protocol’s safety backstop mechanism on Ethereum V3, where participants stake assets to cover potential shortfalls. The tracked stake figur...
SEC Approves Cboe Binary Options Rules for Coinbase and MARA Metrics
The SEC has approved rule changes submitted by Cboe, clearing the regulatory path for a new class of binary options contracts linked to business metrics of Coin...
Bitcoin ETFs vs. Ethereum ETFs: Weekly Outflow Comparison
Net flow figures aggregate all fund-level movements into a single daily number. A negative weekly total means redemptions exceeded creations across all funds th...
